HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Durvanei Augusto Maria Selected Research

phosphorylethanolamine (phosphoethanolamine)

11/2018Antiproliferative and proapoptotic effects of DODAC/synthetic phosphoethanolamine on hepatocellular carcinoma cells.
7/2013Synthetic phosphoethanolamine induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells through the mitochondrial pathway.
1/2013Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine.
10/2012Synthetic phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase.
1/2012Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Durvanei Augusto Maria Research Topics

Disease

23Neoplasms (Cancer)
09/2020 - 01/2005
16Melanoma (Melanoma, Malignant)
01/2022 - 09/2010
4Neoplasm Metastasis (Metastasis)
11/2014 - 01/2011
3Inflammation (Inflammations)
01/2022 - 11/2014
3Renal Cell Carcinoma (Grawitz Tumor)
01/2016 - 01/2013
2Pain (Aches)
09/2020 - 11/2014
2Hyperalgesia
09/2020 - 01/2014
2Multiple Myeloma
09/2015 - 07/2009
2Ascites
09/2015 - 06/2012
2Carcinoma (Carcinomatosis)
09/2015 - 09/2010
2Leukemia
09/2015 - 09/2010
2Adenocarcinoma
10/2013 - 06/2012
2Breast Neoplasms (Breast Cancer)
07/2013 - 06/2012
2Necrosis
06/2013 - 04/2013
2Carcinogenesis
01/2005 - 01/2003
1COVID-19
10/2022
1Infections
10/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Sarcoma (Soft Tissue Sarcoma)
01/2022
1Cancer Pain
09/2020
1Edema (Dropsy)
09/2020
1Wounds and Injuries (Trauma)
09/2020
1Hyperthyroidism
08/2019
1Hepatocellular Carcinoma (Hepatoma)
11/2018
1Blister (Bulla)
01/2016
1Anemia
01/2015
1Neglected Diseases
06/2013
1Chagas Disease (American Trypanosomiasis)
06/2013
1Mitochondrial Diseases (Mitochondrial Disease)
06/2013

Drug/Important Bio-Agent (IBA)

6Caspase 3 (Caspase-3)IBA
01/2015 - 01/2012
5Proteins (Proteins, Gene)FDA Link
10/2022 - 04/2013
5phosphorylethanolamine (phosphoethanolamine)IBA
11/2018 - 01/2012
4Antineoplastic Agents (Antineoplastics)IBA
12/2018 - 01/2012
3Snake Venoms (Snake Venom)IBA
01/2022 - 01/2011
3dioleyldimethylammonium chlorideIBA
11/2018 - 01/2016
3Liposomes (Liposome)IBA
11/2018 - 01/2016
3Proteasome Endopeptidase Complex (Proteasome)IBA
01/2016 - 12/2010
3CurcuminIBA
01/2015 - 06/2012
3BoronIBA
06/2013 - 08/2012
2Phosphates (Orthophosphate)IBA
01/2022 - 12/2017
2Interleukin-10 (Interleukin 10)IBA
01/2022 - 09/2020
2Messenger RNA (mRNA)IBA
09/2020 - 10/2013
2dimethyldioctadecylammonium (dimethyldioctadecylammonium chloride)IBA
11/2018 - 01/2016
2Cyclin D1IBA
01/2016 - 06/2013
2Dacarbazine (DIC)FDA LinkGeneric
01/2015 - 04/2013
2DisintegrinsIBA
11/2014 - 01/2011
2Metalloproteases (Metalloproteinases)IBA
11/2014 - 01/2011
2Bothrops jararaca VenomIBA
11/2014 - 01/2011
2CaspasesIBA
06/2013 - 01/2013
2Phospholipids (Phosphatides)FDA LinkGeneric
10/2012 - 01/2012
2Annexin A5IBA
06/2012 - 01/2012
2Urethane (Ethyl Carbamate)IBA
01/2005 - 01/2003
1Immunoglobulins (Immunoglobulin)IBA
10/2022
1Phospholipases A2 (Phospholipase A2)IBA
01/2022
1phytobacteriomycin (PBM)IBA
09/2020
1Estrogens (Estrogen)FDA Link
08/2019
1Hormones (Hormone)IBA
08/2019
1Carbon Nanotubes (Carbon Nanotube)IBA
12/2018
1DNA (Deoxyribonucleic Acid)IBA
12/2018
1ZincIBA
09/2015
1AntioxidantsIBA
09/2015
1Rutin (Rutoside)IBA
09/2015
1SuspensionsIBA
11/2014
1PhenanthrolinesIBA
11/2014
1VenomsIBA
01/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2013
1Recombinant ProteinsIBA
06/2013
1benzofuroxanIBA
06/2013
1Proteasome InhibitorsIBA
06/2013
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2013
1Caspase 8 (Caspase-8)IBA
04/2013
1Caspase 9IBA
04/2013
1Choline (Choline Chloride)IBA
03/2013
1Biomarkers (Surrogate Marker)IBA
03/2013
1CreatineIBA
03/2013
1CollagenIBA
01/2013
1Pharmaceutical PreparationsIBA
01/2013
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2013
1Sunitinib (Sutent)FDA Link
01/2013
1Melanins (Melanin)IBA
08/2012
1PENTAIBA
06/2012
1SodiumIBA
06/2012
1Paclitaxel (Taxol)FDA LinkGeneric
06/2012
1IS 35IBA
06/2012
1Apoptosis Regulatory ProteinsIBA
02/2012
1Propidium (Propidium Iodide)IBA
01/2012
1LipidsIBA
01/2012

Therapy/Procedure

8Therapeutics
10/2022 - 07/2009
3Low-Level Light Therapy (LLLT)
09/2020 - 12/2016
3Drug Therapy (Chemotherapy)
01/2015 - 06/2012
3Boron Neutron Capture Therapy
06/2013 - 08/2012
2Lasers (Laser)
09/2020 - 12/2017
2Aftercare (After-Treatment)
08/2020 - 04/2013
1Neoadjuvant Therapy
01/2022
1Transplantation
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
08/2020
1Photochemotherapy (Photodynamic Therapy)
12/2017
1Immunomodulation
01/2015
1Adjuvant Chemotherapy
06/2012